KORU Medical Systems, Inc.
KRMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.51 | -0.14 | -0.21 | -0.12 |
| FCF Yield | -0.92% | -5.09% | -5.11% | -3.53% |
| EV / EBITDA | -30.72 | -11.19 | -14.54 | -16.51 |
| Quality | ||||
| ROIC | -31.00% | -58.22% | -24.13% | -13.58% |
| Gross Margin | 63.40% | 58.59% | 55.09% | 58.62% |
| Cash Conversion Ratio | 0.05 | 0.36 | 0.62 | 0.95 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.45% | 6.68% | 4.89% | 0.47% |
| Free Cash Flow Growth | 71.66% | 30.45% | -74.79% | -160.17% |
| Safety | ||||
| Net Debt / EBITDA | 1.01 | 0.75 | 1.22 | 3.77 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 4.39 | 3.39 | 1.96 | 1.59 |
| Cash Conversion Cycle | 99.26 | 129.60 | 176.22 | 250.18 |